In this study, we extensively studied the molecular mechanism of ENb-TRAIL mediated cell killing in a broad spectrum of colorectal cancer, lung cancer, and glioma cell lines non-responsive to EGFR and death receptor targeted therapies. This evidence concerns the gene EGFR and glioma.